Dr. Cagla Eskicioglu, MD MSc
Claim this profileSt. Joseph's Healthcare
Studies Obesity
Studies Rectal Cancer
4 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Cagla Eskicioglu, MD MSc is currently running
Very Low Energy Diet
for Obesity Before Surgery
The PREPARE Pilot randomized controlled trial (RCT) is a multi-center, parallel, blinded RCT that aims to assess the feasibility of a full RCT comparing preoperative very low energy diets (VLEDs) to standard of care prior to elective non-bariatric surgery for obese patients in terms of overall 30-day postoperative morbidity. Adult patients with body mass indices (BMIs) greater than 30 kg/m2 will be randomized 1:1 to receive 3-weeks of preoperative VLED plus preoperative weight loss counselling or preoperative weight loss counselling alone. This trial will enroll patients to assess recruitment, compliance, and follow-up completion to assess the feasibility of a full RCT powered to assess for differences in 30-day postoperative between VLEDs and standard of care arms.
Recruiting1 award N/A3 criteria
Apixaban
for Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a relatively common disease that effects all age groups and carries significant morbidity and mortality. The initial treatment typically involves both short and long term medication, however when this is not enough to adequately control the disease, surgery is often required. The high morbidity and mortality rates are in part due to the increased rates of venous thromboembolism (VTE) such as deep vein thrombosis (DVT) or pulmonary embolism (PE) which have been shown to develop more frequently in IBD patients compared to the general population. Undergoing abdominal surgery has also been shown to independently increase rates of DVT and PE and since the majority of patients with IBD will undergo surgery at least once in their lifetime, the relative increased risk of developing a VTE is very high. The majority of DVT and PE events in the postoperative IBD population will occur after discharge from hospital and therefore carries significant morbidity and mortality risk in a unmonitored setting. Several studies have demonstrated the benefits and safety of twice daily dosing of oral extended VTE prophylaxis agents in orthopedic and cancer postoperative patients following discharge from hospital. There have been no randomized studies which have evaluated the use of extended postoperative VTE prophylaxis in IBD patients. The purpose of this randomized placebo controlled pilot trial will be to evaluate the efficacy and safety of postoperative VTE prophylaxis in IBD patients following abdominal surgery. If this pilot trial demonstrates efficacy in reducing postoperative DVT and PE rates, safety and feasibility, clinicians will be armed with the knowledge to pursue a larger multicenter randomized trial with the intent of reducing overall morbidity and mortality in this high risk population.
Recruiting2 awards Phase < 16 criteria
More about Cagla Eskicioglu, MD MSc
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Cagla Eskicioglu, MD MSc has experience with
- Very Low Energy Diet
- Apixaban
- Placebo Oral Tablet
- Epidural Anesthesia
- Preoperative Very Low Energy Diets
Breakdown of trials Cagla Eskicioglu, MD MSc has run
Obesity
Colorectal Cancer
Blood Clot
Ulcerative Colitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Cagla Eskicioglu, MD MSc specialize in?
Cagla Eskicioglu, MD MSc focuses on Obesity and Rectal Cancer. In particular, much of their work with Obesity has involved treating patients, or patients who are undergoing treatment.
Is Cagla Eskicioglu, MD MSc currently recruiting for clinical trials?
Yes, Cagla Eskicioglu, MD MSc is currently recruiting for 2 clinical trials in Hamilton Ontario. If you're interested in participating, you should apply.
Are there any treatments that Cagla Eskicioglu, MD MSc has studied deeply?
Yes, Cagla Eskicioglu, MD MSc has studied treatments such as Very Low Energy Diet, Apixaban, Placebo Oral Tablet.
What is the best way to schedule an appointment with Cagla Eskicioglu, MD MSc?
Apply for one of the trials that Cagla Eskicioglu, MD MSc is conducting.
What is the office address of Cagla Eskicioglu, MD MSc?
The office of Cagla Eskicioglu, MD MSc is located at: St. Joseph's Healthcare, Hamilton, Ontario L8N 4A6 Canada. This is the address for their practice at the St. Joseph's Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.